Log in

NASDAQ:ANGO - AngioDynamics Stock Price, Forecast & News

$10.43
+0.39 (+3.88 %)
(As of 04/1/2020 05:18 AM ET)
Today's Range
$9.71
Now: $10.43
$10.52
50-Day Range
$8.33
MA: $11.04
$13.20
52-Week Range
$7.48
Now: $10.43
$25.48
Volume443,500 shs
Average Volume364,499 shs
Market Capitalization$392.48 million
P/E Ratio7.14
Dividend YieldN/A
Beta0.85
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Read More
AngioDynamics logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$359.48 million
Cash Flow$1.60 per share
Book Value$16.52 per share

Profitability

Net Income$61.34 million

Miscellaneous

Employees1,050
Market Cap$392.48 million
Next Earnings Date4/7/2020 (Confirmed)
OptionableOptionable

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.


AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

How has AngioDynamics' stock been impacted by COVID-19 (Coronavirus)?

AngioDynamics' stock was trading at $10.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ANGO shares have increased by 2.9% and is now trading at $10.43. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AngioDynamics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AngioDynamics.

When is AngioDynamics' next earnings date?

AngioDynamics is scheduled to release its next quarterly earnings announcement on Tuesday, April 7th 2020. View our earnings forecast for AngioDynamics.

How can I listen to AngioDynamics' earnings call?

AngioDynamics will be holding an earnings conference call on Tuesday, April 7th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings data on Tuesday, January, 7th. The medical instruments supplier reported $0.06 EPS for the quarter, topping the consensus estimate of $0.02 by $0.04. The medical instruments supplier earned $70 million during the quarter, compared to analyst estimates of $71.28 million. AngioDynamics had a return on equity of 3.72% and a net margin of 17.47%. The company's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS. View AngioDynamics' earnings history.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY20 earnings guidance on Tuesday, January, 7th. The company provided earnings per share guidance of $0.10-0.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.13. The company issued revenue guidance of $280-286 million, compared to the consensus revenue estimate of $280.85 million.

What price target have analysts set for ANGO?

1 brokers have issued 1-year price objectives for AngioDynamics' stock. Their forecasts range from $21.00 to $21.00. On average, they expect AngioDynamics' share price to reach $21.00 in the next twelve months. This suggests a possible upside of 101.3% from the stock's current price. View analysts' price targets for AngioDynamics.

Has AngioDynamics been receiving favorable news coverage?

Media headlines about ANGO stock have trended very negative on Wednesday, according to InfoTrie. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. AngioDynamics earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave headlines about the medical instruments supplier a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutAngioDynamics.

Are investors shorting AngioDynamics?

AngioDynamics saw a decrease in short interest in the month of March. As of March 13th, there was short interest totaling 902,900 shares, a decrease of 22.2% from the February 27th total of 1,160,000 shares. Based on an average daily trading volume, of 277,400 shares, the days-to-cover ratio is currently 3.3 days. Currently, 2.5% of the company's shares are short sold. View AngioDynamics' Current Options Chain.

Who are some of AngioDynamics' key competitors?

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Oasis Petroleum (OAS), FireEye (FEYE), Intel (INTC), Mattel (MAT), Bank of America (BAC), Cal-Maine Foods (CALM), Pattern Energy Group (PEGI), Centurylink (CTL) and Freeport-McMoRan (FCX).

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the following people:
  • Mr. James C. Clemmer, CEO, Pres & Director (Age 55)
  • Mr. Michael C. Greiner, Exec. VP & CFO (Age 46)
  • Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 55)
  • Mr. Stephen A. Trowbridge, Sr. VP & Gen. Counsel (Age 45)
  • Mr. Robert A. Simpson, Sr. VP & GM of Vascular Interventions and Therapies (Age 47)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How do I buy shares of AngioDynamics?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $10.43.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $392.48 million and generates $359.48 million in revenue each year. The medical instruments supplier earns $61.34 million in net income (profit) each year or $0.83 on an earnings per share basis. AngioDynamics employs 1,050 workers across the globe. View additional information about AngioDynamics.

What is AngioDynamics' official website?

The official website for AngioDynamics is http://www.angiodynamics.com/.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]


MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  340 (Vote Outperform)
Underperform Votes:  414 (Vote Underperform)
Total Votes:  754
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe ANGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel